Validation of TRI-SCORE for Outcome Prediction After Isolated Tricuspid Valve Surgery in Asian Patients
- PMID: 38563385
- PMCID: PMC11262506
- DOI: 10.1161/JAHA.123.032929
Validation of TRI-SCORE for Outcome Prediction After Isolated Tricuspid Valve Surgery in Asian Patients
Abstract
Background: TRI-SCORE was recently developed in Europe as a risk model for predicting in-hospital death after isolated tricuspid valve surgery. We aimed to validate TRI-SCORE in an Asian population and investigate its value for predicting long-term outcomes.
Methods and results: The TRI-SCORE was calculated for 202 patients (65±11 years, 61% women, 81% functional tricuspid regurgitation) who underwent isolated tricuspid valve surgery for severe tricuspid regurgitation at 2 Korean centers and was based on 8 parameters: age, New York Heart Association class, right-sided heart failure signs, furosemide daily dose, glomerular filtration rate, bilirubin, left ventricular ejection fraction, and moderate/severe right ventricular dysfunction. The primary outcome was all-cause death during follow-up; the secondary outcome was in-hospital death. During a median follow-up duration of 50 (interquartile range, 21-82) months after isolated tricuspid valve surgery, 23 (11.4%) patients experienced the primary outcome, and 7 (3.5%) patients experienced the secondary outcome. Observed all-cause death and in-hospital death increased by up to 50% in those with higher scores. Patients with the primary outcome had a higher TRI-SCORE (4.5±2.4 versus 2.9±2.1; P=0.001) than those without. The TRI-SCORE showed a significant association with the primary outcome (concordance index, 0.77, cutoff value, 4) and in-hospital death (area under the curve, 0.84; cutoff value, 3). Using the Kaplan-Meier analysis, patients with a high TRI-SCORE exhibited a poor outcome for all-cause death at follow-up (log-rank P<0.001) and in-hospital death (log-rank P=0.004).
Conclusions: TRI-SCORE was validated in an Asian population and helped predict long-term outcomes after isolated tricuspid valve surgery.
Keywords: outcomes; risk; surgery; tricuspid regurgitation.
Figures



Similar articles
-
TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.Eur Heart J. 2022 Feb 12;43(7):654-662. doi: 10.1093/eurheartj/ehab679. Eur Heart J. 2022. PMID: 34586392 Free PMC article.
-
Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.Heart. 2023 Aug 24;109(18):1401-1406. doi: 10.1136/heartjnl-2022-322067. Heart. 2023. PMID: 37217297
-
Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation.J Thorac Cardiovasc Surg. 2013 Aug;146(2):278-84. doi: 10.1016/j.jtcvs.2012.04.019. Epub 2012 Aug 4. J Thorac Cardiovasc Surg. 2013. PMID: 22871566
-
Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis.Eur J Cardiothorac Surg. 2018 Oct 1;54(4):644-651. doi: 10.1093/ejcts/ezy150. Eur J Cardiothorac Surg. 2018. PMID: 29897441
-
[Tricuspid valve regurgitation : Indications and operative techniques].Herz. 2017 Nov;42(7):653-661. doi: 10.1007/s00059-017-4603-0. Herz. 2017. PMID: 28801688 Review. German.
Cited by
-
Association of Right Ventricular-Pulmonary Arterial Coupling and Progression of Tricuspid Regurgitation in Patients With Atrial Fibrillation.J Am Heart Assoc. 2025 Mar 18;14(6):e037757. doi: 10.1161/JAHA.124.037757. Epub 2025 Mar 13. J Am Heart Assoc. 2025. PMID: 40079317 Free PMC article.
-
Epidemiology of Valvular Heart Disease in Asia Pacific Region.JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011. Online ahead of print. JACC Asia. 2025. PMID: 40396937 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources